India headlines

5 former Indian School of Business students win $1 million HULT Prize in New York

Nano Health received the prize from Bill Clinton, Muhammad Yunus.

By The American Bazaar Staff

NEW YORK: A group of five alumni from the Indian School of Business (ISB) won the prestigious Hult Prize and a $1 million funding support from the Clinton Global Initiative (CGI).

Bill Clinton along with students
Bill Clinton along with students

The prize was given away by former president Bill Clinton, and Muhammad Yunus, founder of the Grameen Bank, here, on Tuesday.

The winning team – Nano Health – comprised of Aditi Vaish, Ashish Bondia, Manish Ranjan, Pranav Kumar Maranganty, and Ramanathan Lakshmanan. They had participated in the competition earlier this year as students of the Class of 2014 at the ISB.

Ajit Rangnekar, Dean, ISB, was present at the event in New York and shared the historical moment with the team.

Congratulating the Nano Health team, he said, in a statement, “It’s a proud moment for all of us at ISB, as  our alumni team was the first ever entrant from India into the global finals. This is a culmination of the efforts of the students, supported by the faculty, the Max Institute of Healthcare Management at the ISB, and everybody associated with the team.”

The team studied healthcare courses, designed and offered by the Max Institute of Healthcare Management at the ISB. They also received assistance from the Institute, faculty, and the D-Labs accelerator.

The objective of the HULT Prize, the largest student business plan competition in the world, is for teams to design a social enterprise – an annual challenge set by Clinton.

“Solving Non-Communicable Diseases in the Urban Slums” was the challenge for participants this year. All teams had to propose solutions which would impact at least 25 million people in urban and semi urban areas. The ISB group competed against teams from the US, Latin America, the Middle East and China.

Nano Health has received support from industry and the Telangana government to implement their business plan.  They have recently partnered with GVK Biosciences’ proprietary HEART (Health Emphasized Analytical and Reporting Tool).

GVK BIO’s HEART (Health Emphasized Analytical and Reporting Tool) platform is a cloud-based healthcare analytics framework with multiple applications, including the multilingual Disease Management Application.

Leave a Comment

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.